Results 11 to 20 of about 602,916 (384)

Exacerbations of COPD [PDF]

open access: yesEuropean Respiratory Review, 2018
Chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide. While COPD is a mainly chronic disease, a substantial number of patients suffer from exacerbations.
C. Viniol, C. Vogelmeier
semanticscholar   +5 more sources

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

open access: yesMedical Science Monitor, 2023
The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes relevant topics from the clinician’s perspective and evidence published on chronic obstructive pulmonary disease (COPD) since GOLD 2017. The World Health Organization (
D. Parums
semanticscholar   +1 more source

Women's COPD [PDF]

open access: yesFrontiers in Medicine, 2022
Chronic obstructive pulmonary disease (COPD) is no longer a respiratory disease that predominantly affects men, to the point where the prevalence among women has equaled that of men since 2008, partly due to their increasing exposure to tobacco and to biomass fuels. Indeed, COPD has become the leading cause of death in women in the USA.
Maéva Zysman   +3 more
openaire   +4 more sources

Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide

open access: yesGut, 2021
Objective Chronic obstructive pulmonary disease (COPD) is a global disease characterised by chronic obstruction of lung airflow interfering with normal breathing. Although the microbiota of respiratory tract is established to be associated with COPD, the
H. Lai   +9 more
semanticscholar   +1 more source

Pathological Mechanism and Targeted Drugs of COPD

open access: yesInternational Journal of COPD, 2022
Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema, and small airway obstruction. Incompletely reversible airflow limitation, inflammation, excessive mucus secretion and bronchial mucosal epithelial lesions are the main ...
Peng Guo   +5 more
semanticscholar   +1 more source

COPD immunopathology [PDF]

open access: yesSeminars in Immunopathology, 2016
The immunopathology of chronic obstructive pulmonary disease (COPD) is based on the innate and adaptive inflammatory immune responses to the chronic inhalation of cigarette smoking. In the last quarter of the century, the analysis of specimens obtained from the lower airways of COPD patients compared with those from a control group of age-matched ...
CARAMORI, Gaetano   +5 more
openaire   +5 more sources

The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysis

open access: yesJournal of Medical Virology, 2020
Comorbidities are associated with the severity of coronavirus disease 2019 (COVID‐19). This meta‐analysis aimed to explore the risk of severe COVID‐19 in patients with pre‐existing chronic obstructive pulmonary disease (COPD) and ongoing smoking history.
Qianwen Zhao   +7 more
semanticscholar   +1 more source

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

open access: yesmedRxiv, 2020
Background: Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that dramatically spread all over the world in the early part of 2020.
J. Alqahtani   +8 more
semanticscholar   +1 more source

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

open access: yesEuropean Respiratory Journal, 2020
The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) a pandemic [1]. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
J. Leung   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy